VTGN•benzinga•
Vistagen Announces Phase 3 Program For Social Anxiety Disorder With Fasedienol; First Enrollment In U.S. Study For Efficacy, Safety, Tolerability During Public Speaking Challenge
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 10, 2025 by benzinga